•
Dec 31, 2021

The Joint Q4 2021 Earnings Report

The Joint Corp. reported preliminary Q4 2021 financial results, growing revenue compared to Q4 2020.

Key Takeaways

The Joint Corp. reported a revenue of $22.4 million for Q4 2021, compared to $17.0 million in Q4 2020. Net income was $224,000, or $0.01 per diluted share, compared to $10.6 million, or $0.72 per diluted share, in the fourth quarter of 2020.

Revenue was $22.4 million in the fourth quarter of 2021, compared to $17.0 million in the fourth quarter of 2020.

Cost of revenue was $2.4 million, compared to $1.9 million in the fourth quarter of 2020.

Operating income was $663,000, compared to $2.8 million in the fourth quarter of 2020.

Net income was $224,000, compared to $10.6 million in the fourth quarter of 2020.

Total Revenue
$22.4M
Previous year: $17M
+31.7%
EPS
$0.01
Previous year: $0.72
-98.6%
Gross Profit
$20M
Previous year: $15.1M
+32.6%
Cash and Equivalents
$19.5M
Previous year: $20.6M
-5.3%
Free Cash Flow
$1.17M
Previous year: $3.46M
-66.1%
Total Assets
$87.1M
Previous year: $65.9M
+32.2%

The Joint

The Joint

Forward Guidance

Management provided 2022 guidance for revenue, Adjusted EBITDA, and clinic openings.